DalCor Pharmaceuticals Stock

dalcorpharma.comBioTechFounded: 2015

DalCor develops precision treatments for cardiovascular disease by genetically targeting patients that will derive clinical benefits.

Register for Details

For more details on financing and valuation for DalCor Pharmaceuticals, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Other companies like DalCor Pharmaceuticals in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$872.62MM
Sector
Last Round Est. Valuation
$486.63MM
Sector
Last Round Est. Valuation
$186.12MM
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$185MM